Branwen Brockley, Author at Cancer Research UK Cambridge Institute

Dr Raza Ali joins Institute as new Group Leader

We are delighted to announce that Dr Raza Ali will be joining the Institute as a new Junior Group Leader in early 2020.

Institute researchers to work on €30 million Immune-Image consortium

Professor Kevin Brindle and Dr Maike De la Roche to play key roles in a new €30 million Innovative Medicines Initiative grant, supporting research into novel tracer strategies for clinical imaging of immune cell dynamics.

Find out more

International alliance sets bold research ambition to detect the (almost) undetectable

A new transatlantic research alliance developing radical new strategies to detect cancer at its earliest stage.

Find out more

UK-Japan collaboration to understand epigenomes and ageing

The Narita Group have been awarded £490,000 to study epigenomes and ageing from the UK Research and Innovation (UKRI) Fund for International Collaboration, in a joint call with the Japan Society for the Promotion of Science (JSPS).

Highly sensitive blood test could improve breast cancer treatment

A new, highly sensitive blood test is one of the first to successfully monitor breast cancer patients with early stage disease.

Find out more

Institute Group Leaders awarded promotions in the University

Two of our Senior Group Leaders, Jason Carroll and Masashi Narita, have been promoted to professors in this years’ round of Senior Academic Promotions.

Find out more

Fundraiser Annette Beeton’s dedication to charity earns national prize

Over the last 45 years, the Burghley Park and Peterborough Ladies society has raised over £1 million for the Cancer Research UK Cambridge Institute.

Find out more

Strengthening links between Uganda and Cambridge in cancer research

A group of senior representatives from the Uganda Cancer Institute have visited Cambridge to strengthen collaborations and explore further opportunities for improving outcomes for cancer patients both in Uganda and in the UK.

Find out more